Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Jay Stein

Hologic, Inc.

MedTech Engine provides information and resources related to medical breakthroughs, health research, personal health, and medical technology. They cover topics such as chronic illness management, medical procedures, and healthcare industry solutions.

MedTech Engine

RGB Medical Devices specializes in medical technology, providing equipment for operating rooms, intensive care units, and home care settings. The company has been innovating in this field since 1988 and complies with total quality standards.

RGB Medical Devices

MyoSure NL

We’re an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and develop groundbreaking products and services that benefit everyone, we are especially passionate about those that advance women’s health and well-being. This allows us to be a company that prospers, grows and empowers women to experience healthier lives.

None of this would be possible without the talent, skills and aspirations of our employees. Their expertise and dedication to developing and sharing more robust, science-based certainty drives our increasingly global presence, as well as a pipeline that responds to the unmet health and wellness needs of women, families and communities.

What powers our growth across Breast & Skeletal Health, Diagnostic Solutions, and GYN Surgical Solutions is also what differentiates us: the exceptional and clinically proven ability of our products to detect, diagnose and treat illnesses and other health conditions earlier and better. This clinical superiority creates high expectations, which we fulfill by always challenging ourselves to improve health through better technology, education and market access. Our goal is to minimize doubt and maximize the confidence our customers and their patients have in their decisions and diagnoses.

We work toward this goal every day, always aware that in an increasingly complex and competitive global environment, we must continually earn the trust of our customers and their patients. By focusing on women’s health while still delivering health benefits to everyone, we are setting a new standard of excellence that is strengthened by purpose, driven by passion and brought to life by our promise of more certain early detection and better health outcomes.  
To view our community guidelines, visit: www.hologic.com/social-media

Ascent Venture Partners

Reminder! Join Dr. Soyini Hawkins tomorrow, December 13 at 8 p.m. ET / 5 p.m. PT for an Acessa Patient Selection webinar.
Register now: https://bit.ly/3Qd17N6 #Hologic #FibroidAwareness

Join us at ASLM in Cape Town, South Africa from 12-15 December.

Find us at Booth 2, to meet our experts and learn more about our multi-disease testing capabilities and how our extensive portfolio of assays help you meet your lab's growing needs.
Our molecular testing portfolio is designed to bring clinical confidence and workflow efficiency to labs and clinicians whilst guiding patient care and enabling early detection. 

Are you attending?

We are proud to be recognized for the third consecutive year as one of America’s Most Responsible Companies by Newsweek! As a purpose-driven organization championing the health of women, their families and their communities, our employees work every day to be a global force for good. #WhyHologic https://ow.ly/lQV550QgYnr

Meet Gianluca, who is part of our diagnostics team in Italy. He explains how working at Hologic comes with a feeling of connection and belonging with his colleagues thanks to their shared dedication to enabling healthier lives. #WhyHologic

Our dedication to the fight against HIV and AIDS goes back to the 1990s when the National Heart, Lung, and Blood Institute (NHLBI) approached us to develop a nucleic acid blood screening test for the detection of HIV. Today, our cutting-edge HIV detection technology can help patients even more: https://bit.ly/49tsgDf #HIVAwarenessMonth

Join us on Monday, December 11th at 10am ET for “Access Across America: A Year-End Reflection on Women’s Health Policy.” This webinar hosted by our Director of Government Affairs Mia Keeys, will feature a panel of leading women’s health and policy experts reflecting on the developments of the past year and discussing what’s in store for 2024, with a special focus on rural and underserved communities across the United States. Register here: https://bit.ly/49YEV0W

Metric
Company Name	Hologic, Inc.	MedTech Engine	RGB Medical Devices
Symbol	HOLX
MSH ID	COM:HOLOGIC	COM:MEDTECHENGINE	COM:RGB-MEDICAL
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Health Information Services	Medical Devices
Country	US	US	DE
Stage
Employee Count	6.99K
Website	hologic.com	medtechengine.com	rgb-medical.com
LinkedIn	hologic	medtechengine	rgb-medical-devices-s-a-
Founders

Metric
Market Cap	17.68B
Enterprise Value
Monthly Web Traffic	289.96K	46
Web Traffic Growth	0.20	0.15
Valuation
Raised Capital

Metric
Revenue	4.03B
Revenue (LTM)
Revenue (NTM)
Gross Profit	2.23B
EBITDA	882.60M
Operating Income	882.60M
Net Income	789.50M
EPS	3.35
Diluted EPS	3.32
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.62
Operating Profit Margin	0.21
EBITDA Margin	0.22
Net Profit Margin	0.18
Return on Equity	0.14
Return on Assets	0.08
Return on Capital Employed	0.11

COM:HOLOGIC

Hologic

Last Close

78.72

22/11 21:00

Market Cap

17.68B

Beta: -

Volume Today

1.18M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	33.46K
P/B Ratio	3.70K
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	5.45
EV Multiple	19.79

Metric
Days Sales Outstanding	75.72
Days Payables Outstanding	55.31
Days Inventory Outstanding	190.65
Operating Cycle	266.37
Cash Conversion Cycle	211.07
Asset Turnover	0.47

Metric
Operating Cash Flow	1.29B
Free Cash Flow	1.21B
Cash Flow to Debt	0.46
Operating Cash Flow/Sales	0.31
Free Cash Flow Yield	0.05

Metric
Cash & Equivalents	2.16B
Accounts Receivable	41M
Inventory	679.80M
Goodwill
Debt to Capitalization	0.36
Debt to Assets	0.30
Current Ratio	3.89
Quick Ratio	3.32

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03
R&D to Revenue	0.09
SG&A to Revenue	0.12